Case report reveals neurological and imaging features of congenital biotinidase deficiency, suggesting early intervention benefits.
Congenital biotinidase deficiency (CBD) is an uncommon inborn error of metabolism (IEM) that frequently manifests in infancy. Clinical manifestations vary from alopecia rash to severe neurological features like hypotonia, seizures, and developmental delay. Typical imaging manifestations will have symmetric restricted diffusion in the corona radiata, perirolandic white matter, posterior limb of the internal capsule (PLIC), parieto-occipital grey matter, brainstem, middle cerebellar peduncle (MCP), and splenium of the corpus callosum. Early diagnosis is essential because early treatment may reduce or prevent the severity of this disease. Herein, we report a case of CBD presented with breathlessness, alopecia, and hearing loss with typical imaging features, reversed with biotin supplementation in a six-year-old male child.
No takes yet. Share an insight, caveat, or question.
Alagappan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: